Birmingham Bio Innovation Corporation (EIN 934981504) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2023

Legal Domicile

Principal Officer

Sanjay Singh

Phone

2052541986

Tax Period

2024-01-01 to 2024-12-31

Birmingham Bio Innovation Corporation, founded in 2023, is a small nonprofit in the Community Improvement sector that reported $800K in total revenue in fiscal year 2024.

Mission

Birmingham Bio Innovation Corporation's mission is to facilitate and promote the growth of Alabama's biotechnology ecosystem. Building on the region's existing strengths in R&D, fueled by the University of Alabama at Birmingham (the State of Alabama's largest employer) and Southern Research Institute (a translational research institution with a long history of biotech and pharmaceutical research and commercialization), BBIC will advance an innovative biotech economy that attracts and nurtures companies, creates jobs, and improves health outcomes through accelerating the development of drugs, vaccines, and diagnostics.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $800,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $800,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $777,310

Other Expenses $846,207

TOTAL EXPENSES $846,207

Year-over-Year Comparison

	2024	2023	Change
Revenue	$800,000	N/A	N/A
Expenses	$846,207	N/A	N/A
Net Income	$-46,207	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Sanjay Singh	President	1.00	Officer Director	$0	$0	$0
Miller Girvin	Director	0.50	Director	$0	$0	$0
Alesia Jones	Director	0.50	Director	$0	$0	$0
Kathy Nugent	President Elect	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$800,000	$846,207	$5,505,160	$-46,207

Birmingham Bio Innovation Corporation